The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine
about
Designing a VAR2CSA-based vaccine to prevent placental malaria.Bacterial superglue enables easy development of efficient virus-like particle based vaccines.A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA.Comparison of the specificity of antibodies to VAR2CSA in Cameroonian multigravidae with and without placental malaria: a retrospective case-control study.Adhesion of Plasmodium falciparum infected erythrocytes in ex vivo perfused placental tissue: a novel model of placental malaria.Clinical development of placental malaria vaccines and immunoassays harmonization: a workshop report.Antibody responses to the full-length VAR2CSA and its DBL domains in Cameroonian children and teenagers.Pre-clinical and clinical development of the first placental malaria vaccine.Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules.Variant surface antigens of Plasmodium falciparum and their roles in severe malaria.VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria.A VAR2CSA:CSP conjugate capable of inducing dual specificity antibody responses.Adventitious viruses in insect cell lines used for recombinant protein expression.Antibody levels to recombinant VAR2CSA domains vary with Plasmodium falciparum parasitaemia, gestational age, and gravidity, but do not predict pregnancy outcomes.The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent mannerProduction, quality control, stability, and potency of cGMP-produced RH5.1 protein vaccine expressed in S2 cells
P2860
Q34498103-1331F065-A93D-4517-B272-7EAC9E7139BDQ34523734-9FFABA70-1C27-4B6C-9846-82F2BD2468A2Q35850159-94DA8C8B-9A4E-4DA4-AF0B-059F5C9D948EQ36336978-ED5C5735-5AEF-4A4D-8EA4-355B46992171Q36938125-5881F112-FC99-4E86-B2B2-2B62FAF3E1E8Q37263318-37C45F22-33E1-499C-9005-209BAAF27A24Q37396439-AD4F423E-50A8-4631-AC60-0C4B001C8B3AQ38691920-DA37FF9A-9DEB-41F5-AA84-418D7C91B029Q39025466-E8316625-E383-4693-9212-ADF858B19FE3Q39365658-0C50ACB9-1D58-4119-902B-35A5A6EC4DBBQ40670564-F27950BC-AC44-4205-99F0-2B2A6092E6C6Q43924224-1903CAC7-D5F8-4241-ACA6-CA6CFB55888EQ47407694-36A25F15-6BEA-49CE-B2A4-2C5437D05D48Q54258919-B9C63CD0-E7CE-4185-87DA-7AD3030C69AFQ56119780-7C954492-9467-4EC3-A487-87DEAD59A062Q56342201-F83AC950-A464-4A83-9EE9-5064461D35A1
P2860
The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The Influence of Sub-Unit Comp ...... arum Placental Malaria Vaccine
@ast
The Influence of Sub-Unit Comp ...... arum Placental Malaria Vaccine
@en
The Influence of Sub-Unit Comp ...... arum Placental Malaria Vaccine
@nl
type
label
The Influence of Sub-Unit Comp ...... arum Placental Malaria Vaccine
@ast
The Influence of Sub-Unit Comp ...... arum Placental Malaria Vaccine
@en
The Influence of Sub-Unit Comp ...... arum Placental Malaria Vaccine
@nl
prefLabel
The Influence of Sub-Unit Comp ...... arum Placental Malaria Vaccine
@ast
The Influence of Sub-Unit Comp ...... arum Placental Malaria Vaccine
@en
The Influence of Sub-Unit Comp ...... arum Placental Malaria Vaccine
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
The Influence of Sub-Unit Comp ...... arum Placental Malaria Vaccine
@en
P2093
Adrian J F Luty
Anette Strøbæk
Charlotte Dyring
Lars Poulsen
Mafalda Resende
Mette Hamborg
Mette Ø Agerbæk
Odile Leroy
Saddou Issifou
Sisse B Ditlev
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0135406
P407
P50
P577
2015-01-01T00:00:00Z